4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-002080
Chief Executive Officer sold 5,900 shares at $1.20 ($7,080)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian Chief Executive Officer | 2020-01-06 | Sale | −5,900 | $1.20 | $7,080 | 5,804 | D |
| Open-market sales · 5,900 sh · avg $1.20 · $7,080 | |||||||
Loading xslF345X03/a4.xml…